Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$29.05 – $39.93
64% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $53.2M | $70.7M | $93.5M | $115.8M | $137.2M | $140.9M | $138.4M | $148.2M |
| Cost of revenue | $3.7M | $6.5M | $10.9M | $15.5M | $25.2M | $28.1M | $29.3M | $0 |
| Gross profit | $49.5M | $64.2M | $82.7M | $100.3M | $112.0M | $112.9M | $109.2M | $0 |
| Gross margin | 93.0% | 90.8% | 88.4% | 86.6% | 81.6% | 80.1% | 78.9% | 0.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $22.2M | $49.9M | $0 | $37.0M | $38.7M | $37.9M | $32.7M | $0 |
| EBITDA | $40.2M | $50.8M | $53.0M | $85.3M | $102.9M | $111.6M | $91.5M | $77.7M |
| Net income | $13.5M | $9.2M | −$1.9M | $17.6M | $19.1M | $20.6M | $6.6M | −$12.1M |
| Net margin | 25.4% | 13.1% | -2.1% | 15.2% | 14.0% | 14.6% | 4.8% | -8.2% |
| EPS (diluted) | 15.25 | -6.00 | -11.25 | -0.85 | 1.02 | 5.75 | 0.31 | -0.91 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $151M | $0.06 | $0.06–$0.06 | 1 |
| 2027 | $158M | $0.08 | $0.08–$0.08 | 1 |
| 2028 | $161M | $0.40 | $0.40–$0.41 | 1 |
| 2029 | $164M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds GMRE.
No tracked institution reports a position in GMRE as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-19 | $0.7500 | 2026-01-09 |
| 2025-09-29 | $0.7500 | 2025-10-15 |
| 2025-06-20 | $0.1500 | 2025-07-09 |
| 2025-03-21 | $0.2100 | 2025-04-09 |
| 2024-12-20 | $0.2100 | 2025-01-08 |
| 2024-09-20 | $0.2100 | 2024-10-08 |
| 2024-06-21 | $0.2100 | 2024-07-09 |
| 2024-03-21 | $0.2100 | 2024-04-09 |
| 2023-12-26 | $0.2100 | 2024-01-09 |
| 2023-09-21 | $0.2100 | 2023-10-10 |
No one on the platform has traded GMRE yet.
| -1.98% |
| $52M |
| — |
| LOANManhattan Bridge Capital, Inc. | $4.49 | +0.90% | $51M | — |
Source: Financial Modeling Prep · peers by sector/industry
| Execution date | Ratio |
|---|---|
| 2025-09-22 | 1-for-5reverse |
| 2014-11-17 | 1-for-400reverse |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 143.9× earnings vs its 61.1× historical median P/E.
Fair value ≈ $15.26 · price $35.98 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$ADTX the key question isn't just who Jeffrev Busch is. It's what kind of CEO he has been in the past, chiron Real Estate was founded by Jeffrev Busch, who served as Founder Chairman, and CEO from 2014 until June 2025. He built the company into a healthcare-focused REIT with more than 1 billion in enterprise value before handing the CEO role to Mark Decker Jr. while remaining Chairman. $GMRE Trades at $35.00
View on StockTwits ↗$GMRE smart synopsis https://orphanreits.substack.com/p/chirons-100m-vote-of-confidence-and?r=13icl&utm_medium=ios&utm_source=notes-share-action
View on StockTwits ↗$GMRE I like how they quietly cut the dividend. from .75 quarterly to .25 monthly (same). Now they have cut it to .16 monthly an almost -40% cut. https://seekingalpha.com/news/4588196-chiron-real-estate-declares-0_16-dividend
View on StockTwits ↗$GMRE Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.06 down -137.50% YoY • Reported revenue of $38.06M up 9.95% YoY
View on StockTwits ↗$GMRE lol rising today just to dump it all after that poor earnings report.
View on StockTwits ↗$GMRE buy it now ir buy it higher. they are a tsrget - 40% below liquidation value and the bigg doggs are gobbling up portfolios to keep their growth going jus a matter of time new mgmt is set up ti sell
View on StockTwits ↗Initiated a position in $KRC at $28 and $GMRE with my proceeds from $SILA takeout the key to buy the busted net lease reits - ideally health care reits. kilroy inhave a weakspot flr an underdog
View on StockTwits ↗@ItsCarRamRod Funny, mine looks like this without the false drama manufactured at the end So you think Welltower and Ventas -- behemoths on an acquisitions binge trading at 30x -- will ignore these tiny health plays like $SILA and $GMRE
View on StockTwits ↗$GMRE its funny when a company tries to change their name to fool the ALGOs and they end up finding you anyway.
View on StockTwits ↗$GMRE getting shredded just like MPT and all the other crap REITs.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.